Analysts Set Expectations for NTLA FY2027 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at Zacks Research issued their FY2027 EPS estimates for shares of Intellia Therapeutics in a research note issued to investors on Thursday, March 20th. Zacks Research analyst R. Department forecasts that the company will earn ($4.87) per share for the year. The consensus estimate for […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at Zacks Research issued their FY2027 EPS estimates for shares of Intellia Therapeutics in a research note issued to investors on Thursday, March 20th. Zacks Research analyst R. Department forecasts that the company will earn ($4.87) per share for the year. The consensus estimate for […]
